The University of Manchester and The Christie NHS Foundation Trust - both part of the Manchester Cancer Research Centre - has explored the use of patient-reported outcomes to improve the recording of side effects...
"When someone gets cancer, immediately people want to know why," said oncologist Dr. Bert Vogelstein of the Johns Hopkins University School of Medicine in Baltimore...
Cancer death rates hit a peak in 1991, largely driven by tobacco-related lung cancer in men, according to the report.
Read the most recent edition of Kidney Cancer Journal, the only journal dedicated entirely to renal cancers.
Genome variation profiling by genome tiling array
Nearly 25 years ago, Kathleen Zurenko was diagnosed with kidney cancer.
The Supreme Court’s decision to hear arguments in King v. Burwell next year poses an enormous danger to ObamaCare, but it also presents an urgent challenge to the law’s opponents.
"This is an encouraging trend as people are living longer. We just need to make sure we are making the right health policy decisions today to prepare for the health challenges and associated costs that are coming," Murray said in an institute news release.
Immunohistochemical stains have greatly improved the diagnostic accuracy of renal cell carcinoma (RCC) for primary and distant tumours. We evaluate a marker that has recently been incorporated in clinical practice, PAX-8, in primary and metastatic RCCs.
We combined differentially expressed genes, pathways and network analyses to gain new insights into the underlying molecular mechanisms of the disease development.